Determination of Epidermal Growth Factor and Interleukin 6 in Patients with Atopic Dermatitis in karbala Province
Article Sidebar
Main Article Content
Abstract
The most prevalent chronic skin inflammatory illness, Atopic Dermatitis (AD), significantly lowers the quality of life for those who suffer from it. The clinical course, age at onset, and degree of allergy and non-allergic comorbidities associated with AD vary widely. Epidermal growth factor receptor controls a number from keratinocyte processes, including as migration, adhesion, survival, and differentiation. The contrast between differentiation and cell cycle progression is one of these pleiotropic effects that stand out. Also, Interleukin 6 promotes the healing of corneal epithelial wounds. These cytokines may cause corneal neovascularization because they affect different kinds of cells. measurement the concentrations of EGF and interleukin 6 in the serum of men with Atopic Dermatitis and its correlated with severity of the disease. Serum Samples for the current study were collected from 60 serum samples from men with Atopic dermatitis and 60 samples from the control group. All samples were collected from outpatient dermatology clinics in karbala province. The ages of all men ranged between 28 years and 40 years. By ELISA kits, the epidermal growth factor concentrations and interleukin 6 were measured in serum). Results showed significantly increased in levels of EGF and interleukin 6 (p< 0.05) in patient with Atopic Dermatitis compared with control group. These findings imply that EGF might, in an inflammatory setting, collaborate with other cytokines to strengthen the immunological barrier, The pathophysiology of dermatitis is significantly influenced by IL6, and the clinical severity of AD disease development is correlated with elevated levels of this protein.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Abuabara K, Magyari A, McCulloch CE et al. Prevalence of atopic eczema among patients seen in primary care: data from the Health Improvement Network. Ann Intern Med 2019; 170:354–6.
YANG, Eric J., et al. Recent developments in atopic dermatitis. Pediatrics, 2018, 142.4.
Al-Janabi, O. (2014). The Correlation between Nasal Staphylococcus aureus and Persistent Allergic Rhinitis in Comparison with Atopic Dermatitis. Medical Journal of Babylon, 9, 1.
Nemeth V, Evans J. Eczema. [Updated 2022 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available, national library of medicine.
Wang J, Ramette A, Jurca M, Goutaki M, Beardsmore CS, Kuehni CE. Association between breastfeeding and eczema during childhood and adolescence: a cohort study. PLoS One. 2017;12(9):e0185066.
Bylund S, von Kobyletzki LB, Svalstedt M, Svensson A. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol. 2020;100(12):adv00160.
Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, Berger TG, Bergman JN, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Sidbury R. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014 Feb;70(2):338-51.
Tsakok T, Marrs T, Mohsin M, et al. Does atopic dermatitis cause food allergy? A systematic review. J Allergy Clin Immunol. 2016;137(4):1071–8.
Tsakok T, Woolf R, Smith CH, Weidinger S, Flohr C. Atopic dermatitis: the skin barrier and beyond. Br J Dermatol. 2019 Mar;180(3):464-474.
Clausen ML, Edslev SM, Andersen PS, Clemmensen K, Krogfelt KA, Agner T. Staphylococcus aureus colonization in atopic eczema and its association with filaggrin gene mutations. Br J Dermatol. 2017 Nov;177(5):1394-1400.
Malik K, Heitmiller KD, Czarnowicki T. An update on the pathophysiology of atopic dermatitis. Dermatol Clin. 2017;35(3):317– 26.
Wollina U. Microbiome in atopic dermatitis. Clin Cosmet Investig Dermatol. 2017;10:51–6.
Bayer, A.; Lammel, J.; Tohidnezhad, M.; Lippross, S.; Behrendt, P.; Klüter, T.; Pufe, T.; Cremer, J.; Jahr, H.; Rademacher, F.; et al. The Antimicrobial Peptide Human Beta-Defensin-3 Is Induced by Platelet-Released Growth Factors in Primary Keratinocytes. Mediat. Inflamm. 2017, 2017, 6157491.
Singh, M.; Akkaya, S.; Preuß, M.; Rademacher, F.; Tohidnezhad, M.; Kubo, Y.; Behrendt, P.; Weitkamp, J.-T.; Wedel, T.; Lucius, R.; et al. Platelet-Released Growth Factors Influence Wound Healing-Associated Genes in Human Keratinocytes and Ex Vivo Skin Explants. Int. J. Mol. Sci. 2022, 23, 2827.
Bayer, A.; Lammel, J.; Lippross, S.; Klüter, T.; Behrendt, P.; Tohidnezhad, M.; Pufe, T.; Cremer, J.; Jahr, H.; Rademacher, F.; et al. Platelet-released growth factors induce psoriasin in keratinocytes: Implications for the cutaneous barrier. Ann. Anat. Anat. Anz. 2017, 213, 25–32.
Martin P, Nunan R. Cellular and molecular mechanisms of repair in acute and chronic wound healing. Br J Dermatol. 2015; 173(2): 370- 378.
Shin SH, Koh YG,Lee WG, Seok J, Park KY. The use of epidermalgrowth factor in dermatological practice.IntWound J. 2022;1‐10.
Kalay Z, Cevher SC. Oxidant and antioxidant events duringepidermal growth factor therapy to cutaneous wound healingin rats.Int Wound J. 2012;9(4):362-371.
LR, LUCKETT-CHASTAIN. Interleukin (IL)-6 modulates transforming growth factor-beta expression in skin and dermal fibroblasts from IL-6-deficient mice. Br J Dermatol, 2009, 161.2: 237-248.
Lin ZQ, Kondo T, Ishida Y, et al. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J Leukoc Biol. 2003;73:713–21.
Al-lateef, Bareq A.1,; Al-shukri, Maysaa S.M.; Judi, Mohammad Ridha2. Expression of Circulatory Interleukin-6 Concentration Associated with Pseudomonas aeruginosa Persistence in Recurrent Urinary Tract Infections. Medical Journal of Babylon 20(1):p 201-205, Jan–Mar 2023.
Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol 2003; 24:25-9.
Brandt EB, Sivaprasad U. Th2 Cytokines and Atopic Dermatitis. J Clin Cell Immunol. 2011 Aug 10;2(3):110.
HAMEED, Zahraa Ch; AL-ALI, Ibtisam A.; AL-ALAQ, Mousa Muhsin. Effect of dydrogesterone drug on physiological parameters in women with recurrent pregnancy loss. Romanian Journal of Medical Practice, 2024, 19.2.
Hameed, Z., AL-Masaoodi, R., Jabbar, M., Abbas, Z., AL-Wazni, Z. Study of αvß3 integrin gene expression in the endometrium of women with unexplained recurrent Spontaneous abortion. Journal of Bioscience and Applied Research, 2024; 10(5): 63-67.
HENSON, Elizabeth S.; GIBSON, Spencer B. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cellular signalling, 2006, 18.12: 2089-2097.
HOLBRO, Thomas; HYNES, Nancy E. ErbB receptors: directing key signaling networks throughout life. Annu. Rev. Pharmacol. Toxicol., 2004, 44.1: 195-217.
CIARDIELLO, Fortunato; TORTORA, Giampaolo. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clinical Cancer Research, 2001, 7.10: 2958-2970.
LACOUTURE, Mario E. Mechanisms of cutaneous toxicities to EGFR inhibitors. Nature Reviews Cancer, 2006, 6.10: 803-812.
BEREZOV, Alan, et al. Disabling receptor ensembles with rationally designed interface peptidomimetics. Journal of Biological Chemistry, 2002, 277.31: 28330-28339.
ILVES, Tiina; HARVIMA, Ilkka T. Decrease in chymase activity is associated with increase in IL-6 expression in mast cells in atopic dermatitis. Acta Derm Venereol, 2015, 95.4: 411-6.
NAVARINI, Alexander A.; FRENCH, Lars E.; HOFBAUER, Günther FL. Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection. Journal of Allergy and Clinical Immunology, 2011, 128.5: 1128-1130.
Navarini, A.A., French,L.E., and Hofbauer,G.F.L. (2011).InterruptingIL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection. Journal of Allergy and Clinical Immunology,128(5),1128– 1130.